Envoy Medical Files 8-K on Shareholder Nominations
Ticker: COCHW · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1840877
Sentiment: neutral
Topics: corporate-governance, shareholder-nomination, 8-k
TL;DR
Envoy Medical filed an 8-K for shareholder nominations - board changes might be coming.
AI Summary
Envoy Medical, Inc. filed an 8-K on September 6, 2024, to report on shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing does not contain specific financial figures or details about the nominations themselves, but indicates a procedural event related to corporate governance.
Why It Matters
This filing signals potential changes or discussions regarding the composition of Envoy Medical's board of directors, which could impact the company's strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose immediate financial risks or significant operational changes.
Key Players & Entities
- Envoy Medical, Inc. (company) — Registrant
- September 6, 2024 (date) — Filing Date
- Exchange Act Rule 14a-11 (legal_document) — Subject of filing
FAQ
What is the specific purpose of the shareholder nominations mentioned in the filing?
The filing states the nominations are pursuant to Exchange Act Rule 14a-11, but does not provide specific details on the purpose or the nominees.
Does this 8-K filing include any financial information for Envoy Medical, Inc.?
No, this 8-K filing focuses on corporate governance matters and does not include specific financial figures.
When was this 8-K filing submitted to the SEC?
The filing was submitted on September 6, 2024.
What is Envoy Medical, Inc.'s primary business?
Envoy Medical, Inc. is in the business of orthopedic, prosthetic & surgical appliances & supplies, as indicated by its SIC code 3842.
Has Envoy Medical, Inc. changed its name or structure previously?
Yes, the company was formerly known as Anzu Special Acquisition Corp I, with a name change date of January 15, 2021.
Filing Stats: 832 words · 3 min read · ~3 pages · Grade level 13.8 · Accepted 2024-09-06 16:34:04
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share COCH The Nasdaq Stock Mar
- $11.50 — A Common Stock at an exercise price of $11.50 per share COCHW The Nasdaq Stock Ma
Filing Documents
- ea0213819-8k_envoy.htm (8-K) — 42KB
- 0001213900-24-076556.txt ( ) — 258KB
- coch-20240906.xsd (EX-101.SCH) — 4KB
- coch-20240906_def.xml (EX-101.DEF) — 26KB
- coch-20240906_lab.xml (EX-101.LAB) — 36KB
- coch-20240906_pre.xml (EX-101.PRE) — 25KB
- ea0213819-8k_envoy_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENVOY MEDICAL, INC. September 6, 2024 By: /s/ David R. Wells David R. Wells Chief Financial Officer 2